Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
01 1Farmhispania, S.A. Montmeló ES
02 2Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-Lin TW
03 4BIOCON LIMITED Bengaluru IN
04 1BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. Suzhou CN
05 1CKD BIO CORPORATION Sapgyo-eup KR
06 1CONCORD BIOTECH LIMITED Ahmedabad IN
07 1SYNTHON B.V. Nijmegen NL
01 1Everolimus
02 1Everolimus, 0.2% BHT
03 1Everolimus, 0.2% BHT-II
04 1Everolimus, 2% BHT
05 1Everolimus, 2% BHT-II
06 2Everolimus, 2.0% BHT
07 1Everolimus, BHT 2.0%
08 1Everolimus, Butylated hydroxytoluene 2.0%
09 1Everolimus, With antioxidant butylhydroxytoluene 2.0%
10 1Everolimus, with 2% BHT
01 1China
02 5India
03 1Netherlands
04 1South Korea
05 1Spain
06 2Taiwan
01 11Valid
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
Certificate Number : R0-CEP 2019-256 - Rev 02
Status : Valid
Issue Date : 2023-04-27
Type : Chemical
Substance Number : 2918
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Certificate Number : R0-CEP 2020-367 - Rev 01
Status : Valid
Issue Date : 2023-05-16
Type : Chemical
Substance Number : 2918
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Everolimus, With Antioxidant Butylhydroxytoluene...
Certificate Number : CEP 2021-192 - Rev 02
Status : Valid
Issue Date : 2024-02-22
Type : Chemical
Substance Number : 2918
Certificate Number : R0-CEP 2019-323 - Rev 00
Status : Valid
Issue Date : 2022-01-31
Type : Chemical
Substance Number : 2918
Certificate Number : R0-CEP 2020-072 - Rev 01
Status : Valid
Issue Date : 2023-04-19
Type : Chemical
Substance Number : 2918
Certificate Number : R0-CEP 2022-235 - Rev 00
Status : Valid
Issue Date : 2022-08-26
Type : Chemical
Substance Number : 2918
Certificate Number : R0-CEP 2022-143 - Rev 00
Status : Valid
Issue Date : 2022-08-31
Type : Chemical
Substance Number : 2918
Everolimus, Butylated Hydroxytoluene 2.0%
Certificate Number : CEP 2022-367 - Rev 00
Status : Valid
Issue Date : 2024-02-15
Type : Chemical
Substance Number : 2918
Certificate Number : CEP 2019-321 - Rev 01
Status : Valid
Issue Date : 2023-11-30
Type : Chemical
Substance Number : 2918
Certificate Number : CEP 2021-260 - Rev 01
Status : Valid
Issue Date : 2024-02-23
Type : Chemical
Substance Number : 2918
A Everolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Everolimus, including repackagers and relabelers. The FDA regulates Everolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Everolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Everolimus manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Everolimus supplier is an individual or a company that provides Everolimus active pharmaceutical ingredient (API) or Everolimus finished formulations upon request. The Everolimus suppliers may include Everolimus API manufacturers, exporters, distributors and traders.
click here to find a list of Everolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Everolimus CEP of the European Pharmacopoeia monograph is often referred to as a Everolimus Certificate of Suitability (COS). The purpose of a Everolimus CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Everolimus EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Everolimus to their clients by showing that a Everolimus CEP has been issued for it. The manufacturer submits a Everolimus CEP (COS) as part of the market authorization procedure, and it takes on the role of a Everolimus CEP holder for the record. Additionally, the data presented in the Everolimus CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Everolimus DMF.
A Everolimus CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Everolimus CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Everolimus suppliers with CEP (COS) on PharmaCompass.
We have 7 companies offering Everolimus
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
